Clinical Trial Update: A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 3]

View source ↗

Summary

Phase 3 open-label trial assessing dasiglucagon for efficacy and safety in children with congenital hyperinsulinism completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• dasiglucagon (dasiglucagon)

Snippet

Sponsor: Zealand Pharma | Conditions: Congenital Hyperinsulinism | Phase 3 | Status: COMPLETED | Results posted: 2023-12-13